ARTICLE | Company News
Amarna Therapeutics, CBMed deal
August 3, 2015 7:00 AM UTC
Amarna and CBmed partnered to develop immunotherapies to treat acute lymphoblastic leukemia (ALL), obesity, Type II diabetes and atherosclerotic cardiovascular disease. Amarna will provide its SVac v...